Control Bionics Limited (CBL) is a pioneering medical device company dedicated to supporting patients facing challenges in verbal and textual communication due to illnesses such as Motor Neurone Disease (MND) and Amyotrophic Lateral Sclerosis (ALS). Operating across North America, Australia, Singapore, and Japan, Control Bionics leverages innovative technology to provide solutions that empower individuals with limited communication abilities. Their efforts focus on enhancing accessibility and improving quality of life through advanced assistive devices tailored to meet the unique needs of patients worldwide.